Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Regulatory B cells contribute to allergen-encapsulating nanoparticle immunotherapy efficacy for food allergy.

JCI insight·2026

Same author

Immune Biomarkers of Islet Transplant Rejection Revealed by Synthetic Immunological Niche.

bioRxiv : the preprint server for biology·2026

Same author

Nanoparticle modulation of immune and vascular microenvironment dynamics following spinal cord injury.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026

Same author

Nanoparticle induction of antigen-presenting monocyte-derived dendritic cells relieves immunosuppression and inhibits metastasis.

Cell biomaterials·2026

Same author

A VLP-based immunogen that elicits selective anti-Myostatin antibodies, enhances muscle mass and strength, and reduces adiposity.

bioRxiv : the preprint server for biology·2026

Same author

Synthetic Immunological Niche Reveals Early Immune Dysregulation and Stratifies Therapeutic Response in Type 1 Diabetes.

bioRxiv : the preprint server for biology·2026

Same journal

Engineering Functional Graphenic Materials for Bone Repair.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026

Same journal

Breaking Through the Limits: Nanomedicine at the Service of New Drug Combinations to Tackle Pancreatic Cancer.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026

Same journal

Advances in Engineered Virus-Like Particles for Applications in Nanomedicine.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026

Same journal

Lipid- and Polymer-Based Nanoscale Delivery of Anti-Aging Phytochemicals.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026

Same journal

Nano-Enabled Toxicity of Pharmaceutical Excipients.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026

Same journal

Advances in Self-Assembly Artificial Chaperone for Protein Folding Regulation.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 2, 2026

Synthesis of Immunotargeted Magneto-plasmonic Nanoclusters

Synthesis of Immunotargeted Magneto-plasmonic Nanoclusters

Published on: August 22, 2014

Targeted immunomodulation using antigen-conjugated nanoparticles.

Derrick P McCarthy¹, Zoe N Hunter, Bryce Chackerian

¹Department of Microbiology-Immunology and Interdepartmental Immunobiology Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology

|March 12, 2014

Summary

This summary is machine-generated.

Nanoparticles (NPs) offer targeted immunomodulation in medicine, but their impact on the immune system requires further study. Careful design of NP platforms and delivery is crucial for beneficial immune responses.

More Related Videos

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

Related Experiment Videos

Last Updated: May 2, 2026

Synthesis of Immunotargeted Magneto-plasmonic Nanoclusters

Synthesis of Immunotargeted Magneto-plasmonic Nanoclusters

Published on: August 22, 2014

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

Area of Science:

Nanomedicine
Immunology
Materials Science

Background:

Nanotechnology is increasingly used in biology, medicine, and pharmaceuticals.
Limited data exists on nanoparticle interactions with the immune system.
Understanding nanoparticle toxicity and immune system mechanisms is critical.

Purpose of the Study:

To explore the impact of nanoparticles on the immune system.
To investigate mechanisms of nanoparticle-immune system interactions.
To highlight the potential for targeted immunomodulation using nanoparticles.

Main Methods:

Review of existing literature on nanoparticle-immune system interactions.
Analysis of nanoparticle design parameters influencing immunomodulation.
Discussion of strategies for targeted delivery and immune response modulation.

Main Results:

Nanoparticles can be engineered to suppress, enhance, or evade immune recognition.
Targeted immunomodulation is achievable through particle modification and drug/gene delivery.
Design considerations include NP platform, ligands, delivery route, and target immune cells.

Conclusions:

Further research is needed to fully understand nanoparticle-immune system dynamics.
Strategic design of nanoparticles is essential for therapeutic applications.
Tailoring nanoparticles can lead to desired immune responses for medical benefit.